Lambert-Eaton myasthenic syndrome (LEMS) has been linked to cancer, with more than half of LEMS patients having cancer, most of them a small cell lung cancer (SCLC). Researchers have now reported a rare case of LEMS associated with two types of cancer in a patient: breast cancer and small cell…
News
University of Missouri researchers presented a rare case of Lambert–Eaton myasthenic syndrome (LEMS) that initially showed eye muscle weakness as a primary symptom in a 59-year-old woman, according to a report in the journal Cureus. Myasthenia gravis and LEMS are two autoimmune disorders that share a…
Catalyst Pharmaceuticals filed a New Drug Application (NDA) with the U.S. Food and Drug Administration for Firdapse (amifampridine) as a treatment for Lambert-Eaton myasthenic syndrome (LEMS). “We are pleased to reach this regulatory milestone and believe that our NDA submission contains all of the necessary information…
Recent Posts
- Lung cancer therapy triggers severe LEMS muscle weakness for man, 76 June 17, 2026
- The lessons I’ve learned from my daughter’s journey with LEMS June 15, 2026
- Italian pharma gets LEMS drug Firdapse, enters US market in $4B deal May 20, 2026
- A solo flight is a step toward independence for our daughter May 18, 2026
- Normal muscle strength test results may hide LEMS, delay diagnosis April 15, 2026
- Rediscovering my love of reading now that my daughter is doing well April 13, 2026
- No evidence of cancer found in rare case of older man with LEMS March 18, 2026
- After 6 years, my daughter changed her LEMS treatment plan March 16, 2026
- In first reported case, using efgartigimod helps manage LEMS February 18, 2026
- Community support is the driving force behind growing association February 16, 2026